• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ascending thoracic aortic aneurysms protect against myocardial infarctions.升主动脉瘤可预防心肌梗死。
Int J Angiol. 2014 Sep;23(3):177-82. doi: 10.1055/s-0034-1382288.
2
Prevalence of Thoracic Aortic Aneurysms in Patients with Degenerative Abdominal Aortic Aneurysms: Results from the Prospective ACTA Study.胸主动脉瘤在退行性腹主动脉瘤患者中的发生率:前瞻性 ACTA 研究结果。
Eur J Vasc Endovasc Surg. 2021 Jun;61(6):930-937. doi: 10.1016/j.ejvs.2021.03.004. Epub 2021 Apr 20.
3
Synchronous and Metachronous Thoracic Aortic Aneurysms in Patients With Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis.胸主动脉瘤与腹主动脉瘤患者的同期和异时性胸主动脉瘤:系统评价和荟萃分析。
J Am Heart Assoc. 2020 Nov 3;9(21):e017468. doi: 10.1161/JAHA.120.017468. Epub 2020 Oct 26.
4
Pelvic artery aneurysm screening provides value in patients with thoracic aortic aneurysms.盆腔动脉动脉瘤筛查对胸主动脉瘤患者具有价值。
Int J Cardiovasc Imaging. 2017 Oct;33(10):1627-1635. doi: 10.1007/s10554-017-1178-z. Epub 2017 May 27.
5
Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms.胸主动脉瘤和腹主动脉瘤患者之间动脉粥样硬化特征的差异。
Am J Cardiol. 2008 Mar 1;101(5):696-9. doi: 10.1016/j.amjcard.2007.10.039. Epub 2007 Dec 21.
6
Prevalence of thoracic aortic aneurysms and dilatations in patients with intracranial aneurysms.颅内动脉瘤患者的胸主动脉瘤和扩张的患病率。
J Vasc Surg. 2019 Dec;70(6):1801-1808. doi: 10.1016/j.jvs.2019.01.066. Epub 2019 Jul 18.
7
Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms.在一种新型胸主动脉瘤模型中,抑制白细胞介素-1β可减少动脉瘤的形成和进展。
Circulation. 2014 Sep 9;130(11 Suppl 1):S51-9. doi: 10.1161/CIRCULATIONAHA.113.006800.
8
Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease.用于区分胸主动脉瘤疾病病因亚型的血浆生物标志物。
J Thorac Cardiovasc Surg. 2013 May;145(5):1326-33. doi: 10.1016/j.jtcvs.2012.12.027. Epub 2013 Jan 11.
9
Coronary artery aneurysms associated with ascending aortic aneurysms and abdominal aortic aneurysms: pathophysiologic implications.与升主动脉瘤和腹主动脉瘤相关的冠状动脉瘤:病理生理学意义。
Catheter Cardiovasc Interv. 2015 May;85(6):961-7. doi: 10.1002/ccd.25726. Epub 2014 Nov 22.
10
Evaluation for abdominal aortic aneurysms is justified in patients with thoracic aortic aneurysms.对于患有胸主动脉瘤的患者,对腹主动脉瘤进行评估是合理的。
Int J Cardiovasc Imaging. 2016 Apr;32(4):647-53. doi: 10.1007/s10554-015-0807-7. Epub 2015 Nov 24.

引用本文的文献

1
Diabetes is not a negative prognostic factor for 30-days mortality after surgery for acute type A aortic dissection.糖尿病并非急性A型主动脉夹层手术后30天死亡率的不良预后因素。
Cardiovasc Endocrinol Metab. 2024 Jun 19;13(3):e0306. doi: 10.1097/XCE.0000000000000306. eCollection 2024 Sep.
2
Evidence Accumulates: Patients with Ascending Aneurysms Are Strongly Protected from Atherosclerotic Disease.证据不断积累:升主动脉瘤患者可强烈预防动脉粥样硬化性疾病。
Int J Mol Sci. 2023 Oct 27;24(21):15640. doi: 10.3390/ijms242115640.
3
"Big Data" Analyses Underlie Clinical Discoveries at the Aortic Institute.“大数据”分析为主动脉研究所的临床发现提供了依据。
Yale J Biol Med. 2023 Sep 29;96(3):427-440. doi: 10.59249/LNDZ2964. eCollection 2023 Sep.
4
Risk Factors for Mortality From Aortic Aneurysm and Dissection: Results From a 26-Year Follow-Up of a Community-Based Population.主动脉瘤和夹层致死的风险因素:一项基于社区人群的 26 年随访研究结果。
J Am Heart Assoc. 2023 Apr 18;12(8):e027045. doi: 10.1161/JAHA.122.027045. Epub 2023 Apr 12.
5
Trp719Arg Genetic Variant Increases Risk for Thoracic Aortic Dissection.TRP719ARG 基因变异增加胸主动脉夹层风险。
Genes (Basel). 2023 Jan 18;14(2):252. doi: 10.3390/genes14020252.
6
Coronary artery disease in aortic aneurysm and dissection.主动脉瘤和夹层中的冠状动脉疾病。
Indian J Thorac Cardiovasc Surg. 2022 Apr;38(Suppl 1):115-121. doi: 10.1007/s12055-021-01265-3. Epub 2021 Nov 8.
7
Extent of Coronary Artery Disease in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valves.狭窄性二叶瓣主动脉瓣与三叶瓣主动脉瓣患者的冠状动脉疾病严重程度。
J Am Heart Assoc. 2021 Jun 15;10(12):e020080. doi: 10.1161/JAHA.120.020080. Epub 2021 Jun 2.
8
Stanford type B aortic dissection is more frequently associated with coronary artery atherosclerosis than type A.与A型主动脉夹层相比,B型主动脉夹层更常与冠状动脉粥样硬化相关。
J Cardiothorac Surg. 2018 Jun 27;13(1):80. doi: 10.1186/s13019-018-0765-y.
9
Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic Effects.具有抗动脉粥样硬化作用的升主动脉动脉瘤基因突变
Int J Angiol. 2015 Sep;24(3):189-97. doi: 10.1055/s-0035-1556075. Epub 2015 Aug 17.

本文引用的文献

1
Carotid intima-media thickness provides evidence that ascending aortic aneurysm protects against systemic atherosclerosis.颈动脉内膜中层厚度提供了升主动脉瘤可预防全身性动脉粥样硬化的证据。
Cardiology. 2012;123(2):71-7. doi: 10.1159/000341234. Epub 2012 Sep 18.
2
Natural history of thoracic aortic aneurysms.胸主动脉瘤的自然史。
J Vasc Surg. 2012 Aug;56(2):565-71. doi: 10.1016/j.jvs.2012.04.053.
3
Molecular imaging of aortic aneurysms.主动脉瘤的分子成像
Circ Cardiovasc Imaging. 2012 May 1;5(3):392-9. doi: 10.1161/CIRCIMAGING.112.973727.
4
Femoral artery cannulation for thoracic aortic surgery: safe under transesophageal echocardiographic control.经食管超声心动图控制下的股动脉插管用于胸主动脉手术:安全。
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1478-81. doi: 10.1016/j.jtcvs.2011.04.005.
5
Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromsø study.腹主动脉瘤中的动脉粥样硬化:因果事件还是平行发生的过程?特罗姆瑟研究。
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1263-8. doi: 10.1161/ATVBAHA.110.203588. Epub 2010 Apr 1.
6
Acute aortic syndromes and thoracic aortic aneurysm.急性主动脉综合征与胸主动脉瘤
Mayo Clin Proc. 2009 May;84(5):465-81. doi: 10.1016/S0025-6196(11)60566-1.
7
Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components.人类从动脉粥样硬化转变为主动脉瘤的过程与RAS组分表达增加相吻合。
Atherosclerosis. 2009 Aug;205(2):396-403. doi: 10.1016/j.atherosclerosis.2009.01.003. Epub 2009 Jan 13.
8
Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm.转化生长因子-β的过表达与马凡综合征主动脉瘤中透明质酸含量增加及修复受损有关。
Circulation. 2006 Jul 4;114(1 Suppl):I371-7. doi: 10.1161/CIRCULATIONAHA.105.000927.
9
Increased TNF-alpha and decreased TGF-beta expression in peripheral blood leukocytes after acute myocardial infarction.急性心肌梗死后外周血白细胞中肿瘤坏死因子-α表达增加,转化生长因子-β表达减少。
Horm Metab Res. 2006 May;38(5):346-51. doi: 10.1055/s-2006-925403.
10
Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.经血管造影证实的冠心病患者中转化生长因子-β1基因多态性与心肌梗死的关联
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1114-9. doi: 10.1161/01.ATV.0000217747.66517.11. Epub 2006 Mar 16.

升主动脉瘤可预防心肌梗死。

Ascending thoracic aortic aneurysms protect against myocardial infarctions.

作者信息

Chau Katherine, Elefteriades John A

机构信息

Aortic Institute at Yale-New Haven, Yale University, School of Medicine, New Haven, Connecticut.

出版信息

Int J Angiol. 2014 Sep;23(3):177-82. doi: 10.1055/s-0034-1382288.

DOI:10.1055/s-0034-1382288
PMID:25317029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4169096/
Abstract

There has been increasing evidence that ascending thoracic aortic aneurysms (TAAs) protect against atherosclerosis. However, there have been no studies examining the relationship between ascending TAAs and clinical endpoints of atherosclerosis, such as stroke or peripheral arterial disease. In this study, we aim to characterize the relationship between TAAs and a specific clinical endpoint of atherosclerosis, myocardial infarction (MI). We compared prevalence of coronary artery disease (CAD) and MIs in 487 patients who underwent surgical repair for ascending TAAs to 500 control patients who did not have an ascending TAA. Multivariate binary logistic regression was used to calculate the odds of having MI if a patient had an ascending TAA versus any of several MI risk factors. There was a significantly lower prevalence of CAD and MI in the ascending TAA group than in the control TAA group. The odds of having a MI if a patient had a MI risk factor were all > 1 (more likely to have a MI), with the lowest statistically significant odds ratio being 1.54 (age; p = 0.001) and the highest being 14.9 (family history of MI; p < 0.001). The odds ratio of having a MI if a patient had an ascending TAA, however, was near 0 at 0.05 (p < 0.001). This study provides evidence that ascending TAAs protect against MIs, adding further support to the hypothesis that ascending TAAs protect against atherosclerotic disease.

摘要

越来越多的证据表明,升主动脉瘤(TAA)可预防动脉粥样硬化。然而,尚未有研究探讨升主动脉瘤与动脉粥样硬化临床终点(如中风或外周动脉疾病)之间的关系。在本研究中,我们旨在明确升主动脉瘤与动脉粥样硬化的一个特定临床终点——心肌梗死(MI)之间的关系。我们将487例行升主动脉瘤手术修复的患者的冠心病(CAD)和心肌梗死患病率与500例无升主动脉瘤的对照患者进行了比较。采用多变量二元逻辑回归计算患者患有升主动脉瘤时发生心肌梗死的几率与几种心肌梗死危险因素中的任何一种相比的情况。升主动脉瘤组的CAD和MI患病率显著低于对照升主动脉瘤组。如果患者有心肌梗死危险因素,发生心肌梗死的几率均>1(更有可能发生心肌梗死),统计学上最低的显著优势比为1.54(年龄;p = 0.001),最高为14.9(心肌梗死家族史;p < 0.001)。然而,如果患者患有升主动脉瘤,发生心肌梗死的优势比在0.05时接近0(p < 0.001)。本研究提供了证据表明升主动脉瘤可预防心肌梗死,进一步支持了升主动脉瘤可预防动脉粥样硬化疾病的假说。